Yahoo Web Search

Search results

1. • 

     Sanders launches Senate investigation into ‘outrageously high’ pricing of Ozempic, Wegovy

     WKBT La Crosse· 13 hours ago

     The Vermont senator, an independent who has long called out drug manufacturers for their costly...

2. • 

     Markets News, April 24, 2024: Stocks Close Little Changed; Tesla Surges Post-Earnings

     Investopedia· 13 hours ago

     Boeing (BA) shed 2.9% despite reporting a smaller-than-expected loss in the first quarter as it...

3. • 

     5 important insurance questions to ask your hearing aid provider

     Tampa Bay Times· 3 days ago

     Medicare Advantage, and even some commercial/employer insurance plans are listening to their members...

4. • 

     Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight

     GuruFocus.com via Yahoo Finance· 6 days ago

     Dependence on Government-Sponsored Programs: ELV's significant involvement in government-sponsored...

5. • 

     New minimum staffing mandate for nursing homes rolled out by Biden Administration

     WJLA· 2 days ago

     More help could be coming to nursing homes across the country. On Monday, the Biden Administration...

6. • 

     Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut

     WCMH via Yahoo News· 4 days ago

     WASHINGTON (AP) — Rarely a day goes without President Joe Biden mentioning insulin prices. He...

7. • 

     California health workers may face rude awakening with $25 minimum wage law

     Medical Xpress· 7 days ago

     Nearly a half-million health workers who stand to benefit from California's nation-leading $25...

8. • Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake

     Zacks· 1 day ago

     Free Report) reported first-quarter 2024 adjusted earnings per share (EPS) of $3.67, beating the Zacks Consensus Estimate of $3.45. Total revenues came in at $2.29 billion, down 7% on both reported ...

9. • 

     4 Large Drug Stocks to Hold on to Amid Industry Challenges

     Zacks via Yahoo Finance· 20 hours ago

     Drug and biotech companies are likely to see significant innovation. In the Large-Cap...

10. • AccessHope Secures $33 Million in Series B Funding to Expand Access to Leading Cancer Expertise

      ABC 26 New Orleans· 3 days ago

      AccessHope's next phase of growth as a stand-alone company will...product and technology development, oncology network expansion and entering new markets, such as health plans, Medicare ...